Respondents to a survey conducted by GT parent company GenomeWeb offered insight into the SNP/genotyping market. The charts below show when they believe pharmacogenomics will become mainstream, and whom they expect to be the technology leaders.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
A small study finds differences between three genomic prostate cancer tests, Medscape reports.
A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.
In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.
Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.